Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.

Abstract

EMA-CO was highly effective for the management of high-risk GTN, and the toxicities were minimal.

Reproductive outcome after treatment with EMA-CO was excellent.

Full Text

Subjects

Similar articles

Management of resistant gestational trophoblastic tumors. (1998-04-24)
Management of drug resistant gestational trophoblastic neoplasia. (2010-08-27)
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. (2012-10-23)
Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years. (2012-07-30)
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. (2012-12-10)
High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy. (2012-06-15)
High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience. (2010-08-27)
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience. (2007-10-17)
Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. (2006-11-07)

Authors

Publication date

2011-06-20

Journal

The Journal of reproductive medicine
J Reprod Med (0024-7758)

Journal topics

Language

Eng.

Copyright

The Journal of reproductive medicine

Department of Medical Oncology, Cancer Institute (WIA), Tamil Nadu, India. drsanpan80 [at] yahoo.com

Release reference

J Reprod Med. ;56(5-6):219-23

Related books

Español | English

© Galenicom 1999-2013